文献速递胸部肿瘤

放疗相关淋巴细胞减少影响肺癌患者总生存

Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2020-06-14

该研究分析901例肺癌患者,用Cox模型评估总生存预后因素,并通过影像数据挖掘识别与≥3级淋巴细胞减少相关的解剖区域。结果显示≥3级淋巴细胞减少是总生存的独立不良预后因素,相关剂量学参数为胸椎V20、肺平均剂量和心脏平均剂量,并在305例食管癌患者中验证。

要点

  • ≥3级放疗相关淋巴细胞减少是肺癌患者总生存的独立不良预后因素。
  • 与淋巴细胞减少相关的解剖区域为心脏、肺和胸椎。
  • 限制胸椎V20、肺平均剂量和心脏平均剂量可能减轻严重淋巴细胞减少。

核心结论

  • 放疗期间严重淋巴细胞减少是肺癌患者总生存的不良预后因素。
  • 通过限制胸椎V20、肺平均剂量和心脏平均剂量以减少干细胞和血池照射,可能减轻严重淋巴细胞减少。

研究设计与样本

  • 回顾性分析901例肺癌患者,采用Cox模型评估总生存预后因素。
  • 基于肿瘤体积、基线淋巴细胞和处方剂量定义≥3级淋巴细胞减少组与无≥3级淋巴细胞减少组。
  • 使用影像数据挖掘识别剂量与≥3级淋巴细胞减少显著相关的区域,并在305例食管癌患者中验证模型。

主要发现

  • 调整后Cox回归显示≥3级淋巴细胞减少是总生存的独立因素。
  • 识别出的解剖区域为心脏、肺和胸椎。
  • 与淋巴细胞减少相关的剂量学参数包括胸椎V20、肺平均剂量和心脏平均剂量,并在食管癌队列中进一步验证。

关键数值与推荐

  • 胸椎V20、肺平均剂量和心脏平均剂量是与淋巴细胞最低点相关性最高的剂量学参数。

临床怎么用

  • 在肺癌放疗计划评估中关注胸椎V20、肺平均剂量和心脏平均剂量,以降低严重淋巴细胞减少风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lymphopenia after radiotherapy has an adverse effect on the patient's outcome. However, the relationship between radiotherapy dose delivery and lymphopenia is not fully understood. This work used image-based data mining to identify anatomical regions where the received dose is correlated with severe lymphopenia. METHODS: A total of 901 patients with lung cancer were analyzed. A Cox model was used to assess prognostic factors of overall survival (OS). Two matched groups were defined-patients with lymphopenia of grade 3 or higher and patients without lymphopenia of grade 3-based on tumor volume, baseline lymphocytes, and prescribed dose. Then, data mining was used to identify regions where dose correlates significantly with lymphopenia of grade 3 or higher. For this, dose matrices were aligned using registration of the computed tomography images to one reference patient. Mean dose distributions were obtained for the two groups, and organs of significance were detected. Dosimetric parameters from the identified organs that had the highest correlation with lymphocytes at nadir were selected. Multivariable analysis was conducted for lymphopenia of grade 3 or higher on the full lung cohort, and the model was tested on 305 patients with esophageal cancer. RESULTS: Adjusted Cox regression revealed that lymphopenia of grade 3 or higher is an independent factor of OS. The anatomical regions identified were the heart, lung, and thoracic vertebrae. Dosimetric parameters for lymphopenia included thoracic vertebrae V20, mean lung dose, and mean heart dose, which were further validated in the esophageal cancer cohort. CONCLUSIONS: We report that severe lymphopenia during radiotherapy is a poor prognostic factor for OS in patients with lung cancer and could be mitigated by minimizing thoracic vertebrae V20, mean lung dose, and mean heart dose to limit the irradiation of stem cells and blood pool.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Abravan A, Faivre-Finn C, Kennedy J, et al. Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer. J Thorac Oncol. 2020. PMID: 32553694. doi:10.1016/j.jtho.2020.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。